News and Announcements
SUDA Annual Update 2016; IP Filed & Major Deal Signed
- Published January 19, 2017 5:00PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
SUDA Ltd (ASX:SUD) is a drug delivery company headquartered in Perth, WA. The Company is developing low-risk oral sprays using novel formulations of existing pharmaceuticals. The many potential benefits of administering drugs through the cheeks, tongue, gums to include ease of use, lower dosage, reduced side effects and faster response time. During the year, the Company completed an array of achievements;
- Completed the development and filed IP for its novel penetration enhancing technology.
- November 2016, SUDA announced a major deal with Eddingpharm, a leading Chinese pharmaceutical company.
- SUDA’s ZolpiMistÔ oral spray for the treatment of insomnia in China. The total deal value could exceed $34 million in upfront, milestone and royalty payments.
Active discussions are ongoing with approximately 60 pharmaceutical companies.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
